One in eight US adults takes a GLP-1. Almost none pay list price. Here’s what every way to get the drugs actually costs in 2026, from $25 copays to $1,349 retail.
Employee health benefit costs are expected to rise 8.2% on average in 2027 — the highest increase since 2003 – benefits consultancy Marsh says.
Employee health benefit costs are expected to rise 8.2% on average in 2027 — the highest increase since 2003 — according to estimates.
This week’s edition of InnovationRx looks at Vitestro’s newly authorized robot, Italy’s $10 billion pharma family, this year’s Covid-19 vaccines and more.
Since USPSTF recommendations guide insurer decisions on what types of preventive care to fully cover, the panel’s ongoing upheaval may lead to coverage limits.
Forward-deployed engineers are spreading across healthcare, changing how software is built and resurfacing old tensions between customization and scale.
A new molecular glue reprograms the lymphoma protein BCL6 to switch cancer-cell death back on, clearing aggressive tumors in mice in just 11 days.
The Trump administration has mostly shut down the Agency for Healthcare Research and Quality, which has been key in raising awareness and improving patient safety.
A Stanford study’s 12-month follow-up reveals significant improvements in PTSD, depression, and anxiety in Special Operations veterans with TBIs after ibogaine treatment.
A public health researcher raises concerns that the rise of e-scooters and e-bikes might be inadvertently engineering physical activity out of daily life.